Fred Alger Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-308,318
Closed -$879K 488
2025
Q3
$879K Hold
308,318
﹤0.01% 376
2025
Q2
$1.16M Sell
308,318
-223
-0.1% -$877 0.01% 350
2025
Q1
$1.4M Sell
308,541
-64,324
-17% -$340K 0.01% 317
2024
Q4
$2.64M Sell
372,865
-469,644
-56% -$3.74M 0.01% 310
2024
Q3
$6.86M Buy
+842,509
New +$6.09M 0.03% 214

Other funds holding HCAT

Fred Alger Management's HCAT Position: Q4 2025 in Review

Fred Alger Management sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 308,318 shares — an estimated $879K sold.

Fred Alger Management first reported a position in HCAT in Q3 2024 and held it in 5 quarters. The position peaked at $6.86M in Q3 2024. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • Fred Alger Management reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • Fred Alger Management sold 308,318 Health Catalyst shares in Q4 2025, an estimated $879K.
  • Fred Alger Management first reported a position in Health Catalyst in Q3 2024 and held it in 5 quarters.
  • Fred Alger Management's Health Catalyst position peaked at $6.86M in Q3 2024.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Fred Alger Management's 13F filing for Q4 2025, filed 17 Feb 2026.